If you made any changes in Pure these will be visible here soon.

Research Output 2003 2018

2018

Carfilzomib–dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR study

Goldschmidt, H., Moreau, P., Ludwig, H., Niesvizky, R., Chng, W. J., Joshua, D., Weisel, K., Spencer, A., Orlowski, R. Z., Feng, S., Iskander, K. S. & Dimopoulos, M. A., 2018, In : Leukemia and Lymphoma. 59, 6, p. 1364-1374 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma

Yuen, H. L. A., Low, M. S. Y., Fedele, P., Kalff, A., Walker, P., Bergin, K., Coutsouvelis, J., Grigoriadis, G. & Spencer, A., 5 Apr 2018, (Accepted/In press) In : Leukemia and Lymphoma. 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and Challenges

Rodda, A. E., Parker, B. J., Spencer, A. & Corrie, S. R., 23 Mar 2018, In : ACS Sensors. 3, 3, p. 540-560 21 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Resistance to Nutrient Deprivation Via Metabolic Re-Programming As Mechanism of 'Metastasis' Promotion in Multiple Myeloma

Savvidou, I., Khong, T. T. F., Spencer, A., Chen, M., Kalff, A., Masoumi Moghaddam, S., Chandrasekara, S. & Brown, A., Dec 2018.

Research output: Contribution to conferenceAbstractOtherpeer-review

The Canonical Wnt/β-catenin Pathway as a Therapeutic Target in Multiple Myeloma

Savvidou, I., Khong, T., Spencer, A. & Alt, K. M., Jul 2018, In : Archives of Medical Research. 6, 7, p. 1-15 15 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

2017

Adverse impact of high donor CD3+ cell dose on outcome following tandem auto-NMA allogeneic transplantation for high-risk myeloma

Nair, A. P., Walker, P., Kalff, A., Bergin, K., Hocking, J., Avery, S., Curtis, D. J., Patil, S., Das, T., Klarica, D., Morgan, S., Muirhead, J., Gorniak, M. B., Reynolds, J. & Spencer, A., 1 Jun 2017, In : Bone Marrow Transplantation. 52, 6, p. 839-845 7 p.

Research output: Contribution to journalArticleResearchpeer-review

An Evidence-Based Approach to Myeloma Bone Disease

Bingham, N., Reale, A. & Spencer, A., 1 Apr 2017, In : Current Hematologic Malignancy Reports. 12, 2, p. 109-118 10 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis

Gay, F., Oliva, S., Petrucci, M. T., Montefusco, V., Conticello, C., Musto, P., Catalano, L., Evangelista, A., Spada, S., Campbell, P., Ria, R., Salvini, M., Offidani, M., Carella, A-M., Omedé, P., Liberati, A. M., Troia, R., Cafro, A. M., Malfitano, A., Falcone, A. P. & 7 othersCaravita, T., Patriarca, F., Nagler, A., Spencer, A., Hajek, A. R., Palumbo, A. & Boccadoro, M., 1 Aug 2017, In : Leukemia. 31, 8, p. 1727-1734 8 p.

Research output: Contribution to journalArticleResearchpeer-review

BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1

Hogg, S. J., Vervoort, S. J., Deswal, S., Ott, C. J., Li, J., Cluse, L. A., Beavis, P. A., Darcy, P. K., Martin, B. P., Spencer, A., Traunbauer, A. K., Sadovnik, I., Bauer, K., Valent, P., Bradner, J. E., Zuber, J., Shortt, J. & Johnstone, R. W., 28 Feb 2017, In : Cell Reports. 18, 9, p. 2162-2174 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Lee, O. L., Horvath, N., Lee, C., Joshua, D., Ho, J., Szer, J., Quach, H., Spencer, A., Harrison, S. J., Mollee, P., Roberts, A. W., Talaulikar, D., Brown, R. D., Augustson, B. M., Ling, S., Jaksic, W. J., Gibson, J., Kalff, A., Johnston, A., Kalro, A. & 3 othersWard, C., Prince, H. M. & Zannettino, A. C. W., 1 Aug 2017, In : Internal Medicine Journal. 47, 8, p. 938-951 14 p.

Research output: Contribution to journalLetterOtherpeer-review

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma

Mithraprabhu, S., Khong, T., Ramachandran, M., Chow, A., Klarica, D., Mai, L., Walsh, S., Broemeling, D., Marziali, A., Wiggin, M., Hocking, J., Kalff, A., Durie, B. & Spencer, A., 1 Aug 2017, In : Leukemia. 31, 8, p. 1695-1705 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation

Yong, M. K., Cameron, P. U., Slavin, M., Morrissey, C. O., Bergin, K., Spencer, A., Ritchie, D., Cheng, A. C., Samri, A., Carcelain, G., Autran, B. & Lewin, S. R., 1 Jun 2017, In : Journal of Infectious Diseases. 215, 11, p. 1684-1694 11 p.

Research output: Contribution to journalArticleResearchpeer-review

KRAS-Mutated Myeloma Cells Exploit Autophagy and Macropinocytosis to Tolerate Glutamine-Deprived Conditions

Masoumi Moghaddam, S. & Spencer, A., Dec 2017, p. 1786.

Research output: Contribution to conferencePosterOtherpeer-review

Open Access

Low T-cell responses to mitogen stimulation predicts poor survival in recipients of allogeneic hematopoietic stem cell transplantation

Yong, M. K., Cameron, P. U., Slavin, M. A., Cheng, A. C., Orla Morrissey, C., Bergin, K., Spencer, A., Ritchie, D. & Lewin, S. R., 9 Nov 2017, In : Frontiers in Immunology. 8, NOV, 9 p., 1506.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma

Kumar, S. K., Moreau, P., Hari, P., Mateos, M-V., Ludwig, H., Shustik, C., Masszi, T., Spencer, A., Hájek, R., Romeril, K., Avivi, I., Liberati, A. M., Minnema, M. C., Einsele, H., Lonial, S., Berg, D., Lin, J., Gupta, N., Esseltine, D. L. & Richardson, P. G., 1 Aug 2017, In : British Journal of Haematology. 178, 4, p. 571-582 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Myeloma in the real world: What is really happening?

Bergin, K., McQuilten, Z., Moore, E., Wood, E. & Spencer, A., 1 Mar 2017, In : Clinical Lymphoma, Myeloma & Leukemia. 17, 3, p. 133-144.e1 13 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

Quach, H., White, D. J., Spencer, A., Ho, P. J., Bhutani, D., White, M., Inamdar, S., Morris, C., Ou, Y. & Gyger, M., 1 Jun 2017, In : Cancer Chemotherapy and Pharmacology. 79, 6, p. 1067-1076 10 p.

Research output: Contribution to journalArticleResearchpeer-review

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study

Tan, P., Tiong, I. S., Fleming, S., Pomilio, G., Cummings, N., Droogleever, M., McManus, J., Schwarer, A., Catalano, J., Patil, S., Avery, S., Spencer, A. & Wei, A., 2017, In : Oncotarget. 8, 32, p. 52269-52280 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Talaulikar, D., Tam, C. S., Joshua, D. E., Ho, P. J., Szer, J., Quach, H., Spencer, A., Harrison, S. J., Mollee, P., Roberts, A. W., Horvath, N., Lee, C., Zannettino, A. C. W., Brown, R. D., Augustson, B. M., Jaksic, W. J., Gibson, J., Kalff, A., Johnston, A., Trotman, J. & 4 othersKalro, A., Grigoriadis, G., Ward, C. & Prince, H. M., 1 Jan 2017, In : Internal Medicine Journal. 47, 1, p. 35-49 15 p.

Research output: Contribution to journalArticleOtherpeer-review

β-catenin inhibitor BC2059 is efficacious as monotherapy or in combination with proteasome inhibitor bortezomib in multiple myeloma

Savvidou, I., Khong, T., Cuddihy, A., McLean, C., Horrigan, S. & Spencer, A., 1 Sep 2017, In : Molecular Cancer Therapeutics. 16, 9, p. 1765-1778 14 p.

Research output: Contribution to journalArticleResearchpeer-review

2016

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): And randomised, phase 3, open-label, multicentre study

Dimopoulos, M. A., Moreau, P., Palumbo, A., Joshua, D. E., Pour, L., Hájek, R., Facon, T., Ludwig, H., Oriol, A., Goldschmidt, H., Rosiñol, L., Straub, J., Suvorov, A., Araujo, C., Rimashevskaya, E., Pika, T., Gaidano, G., Weisel, K. C., Goranova-Marinova, V., Schwarer, A. & 11 othersMinuk, L., Masszi, T., Karamanesht, I., Offidani, M., Hungria, V., Spencer, A., Orlowski, R. Z., Gillenwater, H. H., Mohamed, N., Feng, S. & Chng, W. J., 1 Jan 2016, In : Lancet Oncology. 17, 1, p. 27-38 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Changes in bone turnover marker levels and clinical outcomes in patients with advanced cancer and bone metastases treated with bone antiresorptive agents

Lipton, A., Smith, M. R., Fizazi, K., Stopeck, A. T., Henry, D. A., Brown, J. E., Shore, N. D., Saad, F., Spencer, A., Zhu, L. & Warner, D. J., 1 Dec 2016, In : Clinical Cancer Research. 22, 23, p. 5713-5721 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Daratumumab, bortezomib, and dexamethasone for multiple myeloma

Palumbo, A., Chanan-Khan, A., Weisel, K. C., Nooka, A. K., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M-V., Mark, T. M., Qi, M., Schecter, J., Amin, H., Qin, X., Deraedt, W., Ahmadi, T., Spencer, A. & Sonneveld, P., 25 Aug 2016, In : New England Journal of Medicine. 375, 8, p. 754-766 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation

Coutsouvelis, J., Avery, S., Dooley, M., Kirkpatrick, C. & Spencer, A., 1 Nov 2016, In : Cancer Treatment Reviews. 50, p. 200-204 5 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry

Bergin, K., Moore, E., McQuilten, Z., Wood, E., Augustson, B., Blacklock, H., Ho, J., Horvath, N., King, T., McNeil, J., Mollee, P., Quach, H., Reid, C. M., Rosengarten, B., Walker, P. & Spencer, A., 9 Nov 2016, In : BMC Medical Research Methodology. 16, 1, 8 p., 151.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Epigenetic regulation of miRNA-124 and multiple downstream targets is associated with treatment response in myeloid malignancies

Liu, H. B., Pattie, P., Chandrasekara, S., Spencer, A. & Dear, A. E., Sep 2016, In : Oncology Letters. 12, 3, p. 2175-2180 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Epigenetics in the biology and treatment of multiple myeloma

Spencer, A. & Mithraprabhu, S., 2016, In : European Oncology & Haematology. 12, 2, p. 96-102 7 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

Open Access
File

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial

Raje, N., Vadhan-Raj, S., Willenbacher, W., Terpos, E., Hungria, V., Spencer, A., Alexeeva, Y., Facon, T., Stewart, A. K., Feng, A., Braun, A., Balakumaran, A. & Roodman, G. D., 8 Jan 2016, In : Blood Cancer Journal. 6, e378.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma

Orlowski, R. Z., Nagler, A., Sonneveld, P., Bladé, J., Hajek, R., Spencer, A., Robak, T., Dmoszynska, A., Horvath, N., Spicka, I., Sutherland, H. J., Suvorov, A. N., Xiu, L., Cakana, A., Parekh, T. & San-Miguel, J. F., 1 Jul 2016, In : Cancer. 122, 13, p. 2050-2056 7 p.

Research output: Contribution to journalArticleResearchpeer-review

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Kumar, S. K., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M-V., Dimopoulos, M. A., Kastritis, E., Boccadoro, M., Orlowski, R. Z., Goldschmidt, H., Spencer, A., Hou, J., Chng, W. J., Usmani, S. Z., Zamagni, E. & 20 othersShimizu, K., Jagannath, S., Johnsen, H. E., Terpos, E., Reiman, A., Kyle, R. A., Sonneveld, P., Richardson, P. G., McCarthy, P. L., Ludwig, H., Chen, W., Cavo, M. M., Harousseau, J. L., Lentzsch, S., Hillengass, J., Palumbo, A., Orfao, A., Rajkumar, S. V., Miguel, J. S. & Avet-Loiseau, H., 1 Aug 2016, In : Lancet Oncology. 17, 8, p. e328-e346

Research output: Contribution to journalReview ArticleResearchpeer-review

Liquid biopsies for liquid tumors: Emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies

Hocking, J., Mithraprabhu, S., Kalff, A. & Spencer, A., 1 Jun 2016, In : Cancer Biology and Medicine. 13, 2, p. 215-225 11 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
File

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients

Levin, N., Spencer, A., Harrison, S. J., Chauhan, D., Burrows, F. J., Anderson, K. C., Reich, S. D., Richardson, P. G. & Trikha, M., 1 Sep 2016, In : British Journal of Haematology. 174, 5, p. 711-720 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Mitochondrial DNA plasticity is an essential inducer of tumorigenesis

Lee, WTY., Cain, JE., Cuddihy, AR., Dickinson, A., Yeung, K-Y., Kumar, B., Johns, TG., Watkins, DN., Spencer, A., St John, JC. & Johnson, J., 2016, In : Cell Death Discovery. 2, p. 1 - 11 11 p., 16016.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Myeloma of the central nervous system - an ongoing conundrum!

Harrison, S. J., Spencer, A. & Quach, H., 2016, In : Leukemia and Lymphoma. 57, 7, p. 1505 - 1506 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Phase i clinical trial of marizomib (NPI-0052) in patients with advanced malignancies including multiple myeloma: Study NPI-0052-102 final results

Harrison, S. J., Mainwaring, P., Price, T., Millward, M. J., Padrik, P., Underhill, C. R., Cannell, P. K., Reich, S. D., Trikha, M. & Spencer, A., 15 Sep 2016, In : Clinical Cancer Research. 22, 18, p. 4559-4566 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: A multicentre audit

Doan, T. N., Kirkpatrick, C. M. J., Walker, P., Slavin, M. A., Ananda-Rajah, M. R., Morrissey, C. O., Urbancic, K. F., Grigg, A. P., Spencer, A., Szer, J., Seymour, J. F. & Kong, D. C. M., 1 Feb 2016, In : Journal of Antimicrobial Chemotherapy. 71, 2, p. 497-505 9 p., dkv343.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study

Vajdic, C. M., Mayson, E., Dodds, A. J., O'Brien, T., Wilcox, L., Nivison-Smith, I., Le Marsney, R., Daniels, B., Ashton, L. J., Tan, J., Bilmon, I., Aarons, D., Tran, S., Gibson, J., Johnston, A., Greenwood, M., Forbes, K. M., Hertzberg, M., Huang, J. G., Spencer, A. & 28 othersMuirhead, J. L., Szer, J., Mason, K., Lewis, I., To, C., Durrant, S., Western, R., Cannell, P., Buffery, S., Oswald, C., Nelson, A., Shaw, P., Pearson, L., Tiedemann, K., Scoyne, M., Fraser, C., Seljak, J., Cole, N. C., Rowland, K., Gough, K. H., Tapp, H., Green, N., Moa, A., McRae, J., Jenkins, M., Hicks, J., Chaplin, K. & CAST study investigators, 1 May 2016, In : Biology of Blood and Marrow Transplantation. 22, 5, p. 949-956 8 p.

Research output: Contribution to journalArticleResearchpeer-review

2015

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia

Kalff, A., Khong, T., Wall, M., Gorniak, M., Mithraprabhu, S., Campbell, L. J. & Spencer, A., 2015, In : Haematologica: the hematology journal. 100, 2, p. e60-e62 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Open Access

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial

Gay, F., Oliva, S., Petrucci, M. T., Conticello, C., Catalano, L., Corradini, P., Siniscalchi, A., Magarotto, V., Pour, L., Carella, A-M., Malfitano, A., Petrò, D., Evangelista, A., Spada, S., Pescosta, N., Omedè, P., Campbell, P., Liberati, A. M., Offidani, M., Ria, R. & 6 othersPulini, S., Patriarca, F., Hajek, R., Spencer, A., Boccadoro, M. & Palumbo, A., 2015, In : Lancet Oncology. 16, 16, p. 1617-1629 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Comment on ?Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma"

Harrison, S. J. A., Quach, H., Spencer, A. & Prince, H. M., 2015, In : Haematologica: the hematology journal. 100, 9, p. 379 - 380 2 p.

Research output: Contribution to journalLetterOther

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation

Pham, T., Patil, S., Fleming, S. A., Avery, S., Walker, P. A., Wei, A., Curtis, D. J., Stuart, G., Klarica, D., O'Brien, M., Morris, K., Das, T. P., Bollard, G. M., Muirhead, J., Coutsouvelis, J. & Spencer, A., 2015, In : Transfusion. 55, 11, p. 2709 - 2713 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

Dimopoulos, M. A., Weisel, K. C., Song, K. W., Delforge, M., Karlin, L., Goldschmidt, H., Moreau, P., Banos, A., Oriol, A., Garderet, L., Cavo, M. M., Ivanova, V., Alegre, A., Martinez-Lopez, J., Chen, C., Spencer, A., Knop, S., Bahlis, N. J., Renner, C., Yu, X. & 5 othersHong, K., Sternas, L., Jacques, C., Zaki, M. & San Miguel, J. F., 2015, In : Haematologica: the hematology journal. 100, 10, p. 1327 - 1333 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Elotuzumab therapy for relapsed or refractory multiple myeloma

Lonial, S., Dimopoulos, M. A., Palumbo, A., White, D. J., Grosicki, S., Spicka, I., Walter-Croneck, A., Moreau, P., Mateos, M-V., Magen, H., Belch, A. R., Reece, D. E., Beksac, M., Spencer, A., Oakervee, H., Orlowski, R. Z., Taniwaki, M., Rollig, C., Einsele, H., Wu, K. L. & 8 othersSinghal, A., San Miguel, J. F., Matsumoto, M., Katz, J., Bleickardt, E., Poulart, V., Anderson, K. C. & Richardson, P. G., 2015, In : New England Journal of Medicine. 373, 7, p. 621 - 631 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia

Wei, A., Tan, P. T. G., Perruzza, S. N., Govindaraj, C., Fleming, S. A., McManus, J. F., Avery, S., Patil, S., Stevenson, W. C., Plebanski, M. & Spencer, A., 2015, In : British Journal of Haematology. 169, 2, p. 199 - 210 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Management of systemic AL amyloidosis: Recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Weber, N., Mollee, P., Augustson, B. M., Brown, R., Catley, L. P., Gibson, J., Harrison, S., Ho, P. J., Horvath, N., Jaksic, W. J., Joshua, D., Quach, H., Roberts, A. W., Spencer, A., Szer, J., Talaulikar, D., To, B., Zannettino, A. C. W. & Prince, H. M., 1 Apr 2015, In : Internal Medicine Journal. 45, 4, p. 371-382 12 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

Asvadi, P., Cuddihy, A. R., Dunn, R., Jiang, V., Wong, M. X., Jones, D. R., Khong, T. T. F. & Spencer, A., 2015, In : British Journal of Haematology. 169, 3, p. 333 - 343 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Modifying chemotherapeutic management of a patient with Burkitt's lymphoma and pre-existing motor neurone disease

Bortz, H. D., Coutsouvelis, J., Corallo, C., Spencer, A. & Patil, S., 2015, In : Journal of Clinical Pharmacy and Therapeutics. 40, 4, p. 483 - 485 3 p.

Research output: Contribution to journalArticleOther